Generic Drug Industry Dynamics
Authors:
- David ReiffenDRDavid Reiffen
- Michael R. WardMWMichael R. Ward
- 1 February 2005
- journal article
- Published by MIT Press in Review of Economics and Statistics
- Vol. 87 (1) , 37-49
Abstract
Oth the economics literature and the business press suggest that a typical pattern for a "new" industry (or what Jovanovic and MacDonald (1994) call an invention )i s to have an initial phase in which a small number of firms each earn significant profits, followed by a phase in which rapid entry of new firms leads to increased competition and dissipation of some of those profits, often accompanied by a shakeout, whereby only a few large firms remain (espe- cially if subsequent innovations increase the optimal scale). Although this pattern seems to characterize many industries, the length of time during which early movers retain their profits, how prices adjust during the entry process, and theKeywords
This publication has 17 references indexed in Scilit:
- A Simple Model of Pharmaceutical Price DynamicsThe Journal of Law and Economics, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- The Impact of Generic Drug Competition on Brand Name Market Shares – Evidence from Micro DataReview of Industrial Organization, 2001
- DYNAMIC GAINS AND STATIC LOSSES IN OLIGOPOLY: EVIDENCE FROM THE BEER INDUSTRYEconomic Inquiry, 1999
- Generic Entry and the Pricing of PharmaceuticalsJournal of Economics & Management Strategy, 1997
- Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug ActThe Journal of Law and Economics, 1992
- Estimation of a Model of Entry in the Airline IndustryEconometrica, 1992
- Entry and Competition in Concentrated MarketsJournal of Political Economy, 1991
- Time Paths in the Diffusion of Product InnovationsThe Economic Journal, 1982
- Industry Structure, Market Rivalry, and Public PolicyThe Journal of Law and Economics, 1973